Abstract 4364380: Outcomes of Coronary Chronic Total Occlusion Modification procedures
Abstract
Background: Chronic total occlusion (CTO) modification procedures are defined as intentional balloon dilatation (diameter ≥2.0 mm) of the entire CTO, including the proximal and distal caps and the CTO body. The outcomes of CTO modification procedures have received limited study. Methods: We analyzed the baseline clinical and angiographic characteristics and outcomes of 2,829 patients, with a total of 2,869 CTOs who underwent a CTO percutaneous coronary intervention (PCI) after a previous failure attempt from the PROGRESS-CTO registry. Results: Of these 2,869 CTO lesions, 600 (20.9%) had undergone modification procedures during the index procedure. Patients who underwent CTO modification were older with higher prevalence of hypertension (92.0% vs 87.6, p=0.005) and dyslipidemia (94.0% vs 83.4%, p<0.001), lower rate of interventional collaterals (49.2 vs 57.5, p<001), higher angiographic complexity, including more moderate/severe calcification (59.4% vs 48.5%, p<0.001) and moderate/severe proximal tortuosity (43.6% vs 30.4%, p<0.001). The most common CTO target vessel in both groups was the Right Coronary Artery (RCA). CTO modification lesions were longer (38.35 vs 30.58 mm, p<0.001) and had higher prevalence of blunt/no stump (63.9% vs 54.5%, p<0.001) and in-stent restenosis (24.6% vs 20.2%, p=0.031), but lower prevalence of side branch at the proximal cap (51.9% vs 61.2%, p<0.001). Lesions that underwent modification had higher J-CTO scores. There was no statistically significant difference in technical (84.1% vs 85.4%, p=0.478) and procedural success (82.7% vs 84.3%, p=0.403) or MACE (1.7% vs 1.8%, p=1.000), between patients who had undergone modification procedures and those who had not. Conclusions: Despite higher lesion complexity CTOs that underwent modification after an unsuccessful initial attempt were recanalized at equally high success and equally low complication rates during the repeat attempt.
Article Details
Authors (25)
Eleni Kladou
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Dimitrios Strepkos
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Michaella Alexandrou
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Deniz Mutlu
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Pedro Carvalho
Ernst Strüngmann Institute
Ozgur Ser
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Khaldoon Alaswad
Henry Ford Cardiovascular Division, Detroit, Michigan, United States
Babar Basir
Henry Ford Cardiovascular Division, Detroit, Michigan, United States
Dmitrii Khelimskii
NMRC E.N. Meshalkin, Novosibirsk, Russian Federation
Oleg Krestyaninov
NMRC E.N. Meshalkin, Novosibirsk, Russian Federation
Jaikirshan Khatri
Weill Cornell Medical Center, New York, New York, United States
Laura Young
Cleveland Clinic Foundation, Cleveland, Ohio, United States
OMER GOKTEKIN
MEMORIAL HOSPITAL, ISTANBUL, Turkey
Paul Poommipanit
University Hospitals, Parma, Ohio, United States
Farouc Jaffer
MASSACHUSETTS GENERAL HOSPITAL, Boston, Massachusetts, United States
Sevket Gorgulu
Biruni University Medical School, Istanbul, Turkey
Diya Arun
Promed Hospital, Chennai, India
Arun Kalyanasundaram
Promed Hospital, Chennai, India
Olga Mastrodemos
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Bavana Rangan
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Sandeep Jalli
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Konstantinos Voudris
Minneapolis Heart Institute, Minneapolis, Minnesota, United States
Yader Sandoval
Allina Health Minneapolis Heart Institute, Abbott Northwestern Hospital and Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation Minneapolis
M Nicholas Burke
Minneapolis Heart Institute, Mpls, Minnesota, United States
Emmanouil Brilakis
Minneapolis Heart Institute, Edina, Minnesota, United States